Clonidine | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Clonidine
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Clonidine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 19 USDMF, 6 CEP/COS, 4 EU WC, 18 NDC API, 11 Listed Suppliers, $ API Reference Price

27 API Suppliers
19 USDMF
6 CEP/COS
4 EU WC
18 NDC API
11 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

FINISHED DOSAGE FORMULATIONS

174 FDF Dossiers, 120 FDA Orange Book, 13 Europe, 14 Canada, 8 Australia, 4 South Africa, 15 Listed Dossiers

174 FDF Dossiers
120 FDA Orange Book
13 Europe
14 Canada
8 Australia
4 South Africa
15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 5 SPI Pharma, 5 DKSH, 1 Pharm-RX Chemical, 7 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 21 BASF, 1 Clariant, 11 Corel Pharma Chem, 6 DFE Pharma, 12 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 30 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 25 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 12 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

70 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 39 Disintegrants & Superdisintegrants, 31 Direct Compression, 28 Granulation, 25 Thickeners and Stabilizers, 24 Controlled & Modified Release, 22 Solubilizers, 17 Lubricants & Glidants, 16 Taste Masking, 16 Parenteral, 13 Film Formers & Plasticizers, 13 Co-Processed Excipients, 10 Topical, 10 Chewable & Orodispersible Aids, 7 API Stability Enhancers, 7 Emulsifying Agents, 6 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Surfactant & Foaming Agents

70 Fillers, Diluents & Binders
47 Coating Systems & Additives
39 Disintegrants & Superdisintegrants
31 Direct Compression
28 Granulation
25 Thickeners and Stabilizers
24 Controlled & Modified Release
22 Solubilizers
17 Lubricants & Glidants
16 Taste Masking
16 Parenteral
13 Film Formers & Plasticizers
13 Co-Processed Excipients
10 Topical
10 Chewable & Orodispersible Aids
7 API Stability Enhancers
7 Emulsifying Agents
6 Rheology Modifiers
5 Empty Capsules
4 Vegetarian Capsules
4 Coloring Agents
3 Surfactant & Foaming Agents

DIGITAL CONTENT

1 STOCK RECAP #PipelineProspector, 33 NEWS #PharmaBuzz

1 STOCK RECAP #PipelineProspector
33 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 17 Finished Drug Prices

3 US Medicaid Prescriptions
17 Finished Drug Prices

MARKET PLACE

10 APIs, 3 FDF Dossiers

10 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents

6 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 4 Others

2 EDQM
2 USP
4 Others

$ API Ref.Price (USD/KG) : 9,552 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 4ATHENA

02 2TRIS PHARMA INC

filter Patent Number Reset all filters

6 All

01 18062667

02 28337890

03 28623409

04 111918689

filter API Patent Reset all filters

6 All

01 6Blank

filter FDF Patent Reset all filters

6 All

01 6Y

filter Expiration Date Reset all filters

6 All

01 22027-04-17

02 12029-03-29

03 22031-09-08

04 12041-07-28

Product Main Page

01

ATHENA

Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

Patent Expiration Date : 2027-04-17

US Patent Number : 8337890

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22500

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-04-17

Athena Company Banner

Product Web Link

Digital Content

02

ATHENA

Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

Patent Expiration Date : 2031-09-08

US Patent Number : 8623409

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22500

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-08

Athena Company Banner

Product Web Link

Digital Content

03

ATHENA

Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

Patent Expiration Date : 2027-04-17

US Patent Number : 8337890

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22500

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-04-17

Athena Company Banner

Product Web Link

Digital Content

04

ATHENA

Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

Patent Expiration Date : 2031-09-08

US Patent Number : 8623409

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22500

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-08

Athena Company Banner

Product Web Link

Digital Content

05

TRIS PHARMA INC

CLONIDINE HYDROCHLORIDE

PharmScience R&D

Not Confirmed

TRIS PHARMA INC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-07-28

CLONIDINE HYDROCHLORIDE

US Patent Number : 11918689

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217645

Patent Use Code : U-3944

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-07-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

TRIS PHARMA INC

CLONIDINE HYDROCHLORIDE

PharmScience R&D

Not Confirmed

TRIS PHARMA INC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-29

CLONIDINE HYDROCHLORIDE

US Patent Number : 8062667

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217645

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!